Ethics of using controls and placebo in clinical trials
Wilde, H.; Phaosavasdi, S.; Pruksapong, C.; Tannirandorn, Y.; Taneepanichskul, S.
Journal of the Medical Association of Thailand 82(6): 632-635
1999
ISSN/ISBN: 0125-2208 PMID: 10443090 Document Number: 501896
Document emailed within 1 workday
Related Documents
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570Bergmann, J.F.; Lagier, G.; Calvo, F.; Chazelle, F.; Caulin, C. 1988: Independent controls of quality in therapeutic trials. Apropos of an experience of 11 external audits of clinical investigators performed in 2 European multicenter trials Therapie 43(5): 379-384
Gehan, E.A. 1982: Design of controlled clinical trials: use of historical controls Cancer Treatment Reports 66(5): 1089-1093
Lilford, R.J. 2002: The ethics of underpowered clinical trials JAMA 288(17): 2118-9; Author Reply 2119
Whalan, D.J. 1975: The ethics and morality of clinical trials in man Medical Journal of Australia 1(16): 491-494
Homb, T. 1993: Ethics and mathematics in clinical trials Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 113(7): 867-868
Lore, W. 1985: Clinical trials and medical ethics East African Medical Journal 62(1): 1-2
Leber, P. 1986: The placebo control in clinical trials (a view from the FDA) Psychopharmacology Bulletin 22(1): 30-32
Del-Ré, R. 1995: Ethics committees and clinical trials: it's more than change of name Medicina Clinica 105(15): 580-582
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
Miller, B.L. 1980: Placebo usage in clinical trials of lifesaving drugs Progress in Clinical and Biological Research 38: 263-274
McCormick, M.C. 1995: Ethics of consent for babies in randomised clinical trials Lancet 345(8961): 1370-1371
Béréterbide, F.; Hirsch, F. 2008: Clinical trials in developing countries: who should define ethics? Bulletin de la Societe de Pathologie Exotique 101(2): 102-105
Greco, D.B. 1999: Clinical trials in "developing" countries: the fallacy of urgency or ethics vs. economics Bulletin of Medical Ethics No. 150: 33-34
1984: Ethics debate heats up as gene therapy moves toward clinical trials Medical World News 25(21): 34 36
Sedivý, J.; Setka, J.; Rusek, J. 1992: The role of ethics committees in evaluating the ethical aspects of clinical drug trials Casopis Lekaru Ceskych 131(17): 539-540
Bystritsky, A.; Waikar, S.V. 1994: Inert placebo versus active medication. Patient blindability in clinical pharmacological trials Journal of Nervous and Mental Disease 182(9): 485-487
Lund, L.H. 2008: Ethics committees in USA--background and development. Responsible conductors of clinical trials required for risk minimization Lakartidningen 105(1-2): 42-44
Walsh, T.L.; Frezieres, R.G.; Peacock, K.; Nelson, A.L.; Clark, V.A.; Bernstein, L.; Wraxall, B.G.D. 2004: Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials Contraception 70(5): 407-413
Murphy, J.; Coxon, R.; Sharpe, D.N. 1985: Practical aspects of clinical trials: a review of a randomized, placebo-controlled study in patients with heart failure Heart and Lung: the Journal of Critical Care 14(1): 95-100